Cardiac insulin resistance and microRNA modulators

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Pulakat, Lakshmi ^a,b   Aroor, Annayya R ^a,b   Gul, Rukhsana ^a,b   Sowers, James R ^a,b,c  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PROTEIN P70; S6 KINASE; ANGIOTENSIN RECEPTOR; MTOR PROTEIN, HUMAN; MTORC1 COMPLEX, HUMAN; PROTEIN; RIBOSOMAL PROTEIN S6 KINASE, 70KD, POLYPEPTIDE 1; TARGET OF RAPAMYCIN KINASE;

ALCOHOL CONSUMPTION; CARDIOMYOPATHY; DIABETES MELLITUS; ENZYME INHIBITION; GENE ACTIVATION; HEART FAILURE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DRINKING BEHAVIOR; GENETICS; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR;

ALCOHOL DRINKING; ANIMALS; CARDIOMYOPATHIES; HUMANS; INSULIN; INSULIN RESISTANCE; MICRORNAS; MYOCARDIUM; OVERNUTRITION; PROTEINS; RECEPTORS, ANGIOTENSIN; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RISK FACTORS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 81555212723     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/654904     Document Type: Review

References (147)

1. Sowers J. R., Whaley-Connell A., Hayden M. R., The role of overweight and obesity in the cardiorenal syndrome CardioRenal Medicine 2011 1 5 12
2. Pulakat L., DeMarco V. G., Whaley-Connell A., Sowers J. R., The impact of overnutrition on insulin metabolic signaling in the heart and the kidney CardioRenal Medicine 2011 2 102 112
3. Sowers J. R., Hypertension, angiotensin II, and oxidative stress The New England Journal of Medicine 2002 346 25 1999 2001 (Pubitemid 34651362)
4. Sowers J. R., Metabolic risk factors and renal disease Kidney International 2007 71 8 719 720 (Pubitemid 46624014)
5. Galassi A., Reynolds K., He J., Metabolic syndrome and risk of cardiovascular disease: a meta-analysis American Journal of Medicine 2006 119 10 812 819 (Pubitemid 44415613)
6. Pettman T. L., Buckley J. D., Coates A. M., Misan G. M. H., Petkov J., Howe P. R. C., Prevalence and interrelationships between cardio-metabolic risk factors in abdominally obese individuals Metabolic Syndrome and Related Disorders 2009 7 1 31 36
7. Crichton G. E., Bryan J., Buckley J., Murphy K. J., Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues Obesity Reviews 2011 12 5 e190 e201
8. de Koning L., Malik V. S., Rimm E. B., Willett W. C., Hu F. B., Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men The American Journal of Clinical Nutrition 2011 93 6 1321 1327
9. Gillingham L. G., Harris-Janz S., Jones P. J., Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors Lipids 2011 46 3 209 228
10. Siri-Tarino P. W., Sun Q., Hu F. B., Krauss R. M., Saturated fat, carbohydrate, and cardiovascular disease American Journal of Clinical Nutrition 2010 91 3 502 509
11. Hu F. B., Willett W. C., Optimal diets for prevention of coronary heart disease Journal of the American Medical Association 2002 288 20 2569 2578 (Pubitemid 35386892)
12. Wilson C. R., Tran M. K., Salazar K. L., Young M. E., Taegtmeyer H., Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats Biochemical Journal 2007 406 3 457 467 (Pubitemid 47425452)
13. Sampey B. P., Vanhoose A. M., Winfield H. M., Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet Obesity 2011 19 6 1109 1117
14. Liu S., Willett W. C., Stampfer M. J., Hu F. B., Franz M., Sampson L., Hennekens C. H., Manson J. E., A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women American Journal of Clinical Nutrition 2000 71 6 1455 1461 (Pubitemid 30395891)
15. Osmond J. M., Mintz J. D., Dalton B., Stepp D. W., Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat Hypertension 2009 53 2 381 386
16. Whaley-Connell A., Sowers J. R., Hypertension and insulin resistance Hypertension 2009 54 3 462 464
17. Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., Nowotny P., Waldhusl W., Marette A., Roden M., Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability Diabetes 2005 54 9 2674 2684 (Pubitemid 41233590)
18. Xiao F., Huang Z., Li H., Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways Diabetes 2011 60 3 746 756
19. Wong C., Marwick T. H., Obesity cardiomyopathy: pathogenesis and pathophysiology Nature Clinical Practice Cardiovascular Medicine 2007 4 8 436 443 (Pubitemid 47189016)
20. Kim J. A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance Circulation Research 2008 102 4 401 414 (Pubitemid 351651099)
21. de Kloet A. D., Krause E. G., Woods S. C., The renin angiotensin system and the metabolic syndrome Physiology and Behavior 2010 100 5 525 534
22. Kotsis V., Stabouli S., Papakatsika S., Rizos Z., Parati G., Mechanisms of obesity-induced hypertension Hypertension Research 2010 33 5 386 393
23. Lastra G., Habibi J., Whaley-Connell A. T., Manrique C., Hayden M. R., Rehmer J., Patel K., Ferrario C., Sowers J. R., Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression Endocrinology 2009 150 6 2561 2568
24. Iwanami J., Mogi M., Iwai M., Horiuchi M., Inhibition of the renin-angiotensin system and target organ protection Hypertension Research 2009 32 4 229 237
25. Werner C. M., Bhm M., Review: the therapeutic role of RAS blockade in chronic heart failure Therapeutic Advances in Cardiovascular Disease 2008 2 3 167 177 (Pubitemid 351863375)
26. Kurtz T. W., Beyond the classic angiotensin-receptor-blocker profile Nature Clinical Practice Cardiovascular Medicine 2008 5 supplement 1 S19 S26 (Pubitemid 351940520)
27. Grobe J. L., Mecca A. P., Lingis M., Shenoy V., Bolton T. A., Machado J. M., Speth R. C., Raizada M. K., Katovich M. J., Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) American Journal of Physiology 2007 292 2 H736 H742
28. Aneja A., Tang W. H. W., Bansilal S., Garcia M. J., Farkouh M. E., Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options American Journal of Medicine 2008 121 9 748 757
29. Allcock D. M., Sowers J. R., Best strategies for hypertension management in type 2 diabetes and obesity Current Diabetes Reports 2010 10 2 139 144
30. Verdecchia P., Angeli F., Mazzotta G., Reboldi G., Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together? Current Vascular Pharmacology 2010 8 6 742 746
31. Braga M. F. B., Leiter L. A., Role of renin-Angiotensin system blockade in patients with diabetes mellitus American Journal of Cardiology 2009 104 6 835 839
32. Grothusen C., Divchev D., Luchtefeld M., Schieffer B., Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Minerva Cardioangiologica 2009 57 6 773 785
33. Sowers J. R., Raij L., Jialal I., Egan B. M., Ofili E. O., Samuel R., Zappe D. H., Purkayastha D., Deedwania P. C., Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives Journal of Hypertension 2010 28 8 1761 1769
34. Lau W. B., Tao L., Wang Y., Li R., Ma X. L., Systemic adiponectin malfunction as a risk factor for cardiovascular disease Antioxidants Redox Signaling 2011 15 7 1863 1873
35. Hug C., Lodish H. F., The role of the adipocyte hormone adiponectin in cardiovascular disease Current Opinion in Pharmacology 2005 5 2 129 134 (Pubitemid 40378742)
36. Jamaluddin M. S., Weakley S. M., Yao Q., Chen C., Resistin: functional roles and therapeutic considerations for cardiovascular disease. British Journal of Pharmacology. In press
37. Pulakat L., Demarco V. G., Ardhanari S., Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 2011. In press
38. Sengupta S., Peterson T. R., Sabatini D. M., Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress Molecular Cell 2010 40 2 310 322
39. Flati V., Pasini E., D'Antona G., Speca S., Toniato E., Martinotti S., Intracellular mechanisms of metabolism regulation: the role of signaling via the mammalian target of rapamycin pathway and other routes American Journal of Cardiology 2008 101 11 S16 S21
40. Cully M., Downward J., Translational responses to growth factors and stress Biochemical Society Transactions 2009 37 1 284 288
41. Conn C. S., Qian S. B., mTOR signaling in protein homeostasis: less is more? Cell Cycle 2011 10 1940 1947
42. Kapahi P., Chen D., Rogers A. N., Katewa S. D., Li P. W. L., Thomas E. L., Kockel L., With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging Cell Metabolism 2010 11 6 453 465
43. Wellen K. E., Thompson C. B., Cellular metabolic stress: considering how cells respond to nutrient excess Molecular Cell 2010 40 2 323 332
44. Zhou H., Huang S., The complexes of mammalian target of rapamycin Current Protein Peptide Science 2010 11 409 424
45. Diniz G. P., Barreto-Chaves M. L. M., Carneiro-Ramos M. S., Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3 /mTOR signaling pathway Basic Research in Cardiology 2009 104 6 653 667
46. Marin T. M., Keith K., Davies B., Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation Journal of Clinical Investigation 2011 121 1026 1043
47. Mueller M. A., Beutner F., Teupser D., Ceglarek U., Thiery J., Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia Atherosclerosis 2008 198 1 39 48 (Pubitemid 351406366)
48. Sampson J. R., Therapeutic targeting of mTOR in tuberous sclerosis Biochemical Society Transactions 2009 37 1 259 264
49. Medeiros C., Frederico M. J., Da Luz G., Pauli J. R., Silva A. S., Pinho R. A., Velloso L. A., Ropelle E. R., De Souza C. T., Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet-induced obesity rats Journal of Cellular Physiology 2011 226 3 666 674
50. Ali S. M., Sabatini D. M., Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site Journal of Biological Chemistry 2005 280 20 19445 19448 (Pubitemid 41379463)
51. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K. I., Hara K., Tanaka N., Avruch J., Yonezawa K., The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif Journal of Biological Chemistry 2003 278 18 15461 15464 (Pubitemid 36799651)
52. Song X., Kusakari Y., Xiao C. Y., Kinsella S. D., Rosenberg M. A., Scherrer-Crosbie M., Hara K., Rosenzweig A., Matsui T., mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy American Journal of Physiology 2010 299 6 C1256 C1266
53. Shen W. H., Chen Z., Shi S., Chen H., Zhu W., Penner A., Bu G., Li W., Boyle D. W., Rubart M., Field L. J., Abraham R., Liechty E. A., Shou W., Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mtor-mediated signaling and cardiac function Journal of Biological Chemistry 2008 283 20 13842 13849
54. Shende P., Plaisance I., Morandi C., Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice Circulation 2011 123 1073 1082
55. Athyros V. G., Liberopoulos E. N., Mikhailidis D. P., Papageorgiou A. A., Ganotakis E. S., Tziomalos K., Kakafika A. I., Karagiannis A., Lambropoulos S., Elisaf M., Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort Angiology 2008 58 6 689 697
56. Schaller G., Kretschmer S., Gouya G., Haider D. G., Mittermayer F., Riedl M., Wagner O., Pacini G., Wolzt M., Ludvik B., Alcohol acutely increases vascular reactivity together with insulin sensitivity in type 2 diabetic men Experimental and Clinical Endocrinology and Diabetes 2010 118 1 57 60
57. Player M. S., Mainous A. G., King D. E., Diaz V. A., Everett C. J., Moderate alcohol intake is associated with decreased risk of insulin resistance among individuals with vitamin D insufficiency Nutrition 2010 26 1 100 105
58. Vary T. C., Lynch C. J., Lang C. H., Effects of chronic alcohol consumption on regulation of myocardial protein synthesis American Journal of Physiology 2001 281 3 H1242 H1251
59. Vary T. C., Deiter G., Lantry R., Chronic alcohol feeding impairs mTOR(Ser2448) phosphorylation in rat hearts Alcoholism: Clinical and Experimental Research 2008 32 1 43 51 (Pubitemid 350301900)
60. Lang C. H., Frost R. A., Summer A. D., Vary T. C., Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart International Journal of Biochemistry and Cell Biology 2005 37 10 2180 2195 (Pubitemid 41206830)
61. Inoki K., Li Y., Zhu T., Wu J., Guan K. L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nature Cell Biology 2002 4 9 648 657 (Pubitemid 34993700)
62. Sancak Y., Bar-Peled L., Zoncu R., Markhard A. L., Nada S., Sabatini D. M., Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids Cell 2010 141 2 290 303
63. Dennis M. D., Baum J. I., Kimball S. R., Jefferson L. S., Mechanisms involved in the coordinate regulation of mTORC1 by insulin and amino acids The Journal of Biological Chemistry 2011 286 8287 8296
64. Hannan R. D., Jenkins A., Jenkins A. K., Brandenburger Y., Cardiac hypertrophy: a matter of translation Clinical and Experimental Pharmacology and Physiology 2003 30 8 517 527 (Pubitemid 37011588)
65. Manning B. D., Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis Journal of Cell Biology 2004 167 3 399 403 (Pubitemid 39489047)
66. Zhang D., Contu R., Latronico M. V. G., Zhang J. L., Rizzi R., Catalucci D., Miyamoto S., Huang K., Ceci M., Gu Y., Dalton N. D., Peterson K. L., Guan K. L., Brown J. H., Chen J., Sonenberg N., Condorelli G., MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice Journal of Clinical Investigation 2010 120 8 2805 2816
67. Zhou X., Ma L., Habibi J., Whaley-Connell A., Hayden M. R., Tilmon R. D., Brown A. N., Kim J. A., Demarco V. G., Sowers J. R., Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the zucker obese rat Hypertension 2010 55 4 880 888
68. Frisbee J. C., Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome Microcirculation 2005 12 5 383 392 (Pubitemid 41122463)
69. Ren J., Pulakat L., Whaley-Connell A., Sowers J. R., Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease Journal of Molecular Medicine 2010 88 10 993 1001
70. Alvarez S. E., Seguin L. R., Villarreal R. S., Nahmias C., Ciuffo G. M., Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues Journal of Cellular Biochemistry 2008 105 3 703 711
71. Kambayashi Y., Nagata K., Ichiki T., Inagami T., Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells European Journal of Biochemistry 1996 239 3 558 565 (Pubitemid 26253027)
72. Samuelsson A. M., Bollano E., Mobini R., Larsson B. M., Omerovic E., Fu M., Waagstein F., Holmng A., Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways American Journal of Physiology 2006 291 2 H787 H796 (Pubitemid 44175086)
73. Booz G. W., Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system Hypertension 2005 45 3 341 346 (Pubitemid 40315798)
74. Bosnyak S., Welungoda I. K., Hallberg A., Alterman M., Widdop R. E., Jones E. S., Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats British Journal of Pharmacology 2010 159 3 709 716
75. Bove C. M., Gilson W. D., Scott C. D., Epstein F. H., Yang Z., Dimaria J. M., Berr S. S., French B. A., Bishop S. P., Kramer C. M., The angiotensin II type 2 receptor and improved adjacent region function post-MI Journal of Cardiovascular Magnetic Resonance 2005 7 2 459 464 (Pubitemid 40563337)
76. Lako-Futo Z., Szokodi I., Sarman B., Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart Circulation 2003 108 2414 2422 (Pubitemid 37413551)
77. Steckelings U. M., Widdop R. E., Paulis L., Unger T., The angiotensin AT2 receptor in left ventricular hypertrophy Journal of Hypertension 2010 28 1 S50 S55
78. Molavi B., Chen J., Mehta J. L., Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK American Journal of Physiology 2006 291 2 H687 H693 (Pubitemid 44175074)
79. Van Kesteren C. A. M., Van Heugten H. A. A., Lamers J. M. J., Saxena P. R., Schalekamp M. A. D. H., Danser A. H. J., Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts Journal of Molecular and Cellular Cardiology 1997 29 8 2147 2157 (Pubitemid 27348525)
80. Yan X., Schuldt A. J. T., Price R. L., Amende I., Liu F. F., Okoshi K., Ho K. K. L., Pope A. J., Borg T. K., Lorell B. H., Morgan J. P., Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes American Journal of Physiology 2008 294 3 H1274 H1281 (Pubitemid 351468724)
81. Ferland-McCollough D., Ozanne S. E., Siddle K., Willisand A. E., Bushell M., The involvement of microRNAs in type 2 diabetes Biochemical Society Transactions 2010 38 6 1565 1570
82. Qin S., Zhang C., MicroRNAs in vascular disease Journal of Cardiovascular Pharmacology 2011 57 8 12
83. Frost R. J. A., Van Rooij E., miRNAs as therapeutic targets in ischemic heart disease Journal of Cardiovascular Translational Research 2010 3 3 280 289
84. Edwards J. K., Pasqualini R., Arap W., Calin G. A., MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases Journal of Cardiovascular Translational Research 2010 3 3 271 279
85. van Rooij E., Quiat D., Johnson B. A., Sutherland L. B., Qi X., Richardson J. A., Kelm R. J., Olson E. N., A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance Developmental Cell 2009 17 5 662 673
86. Callis T. E., Pandya K., Hee Y. S., Tang R. H., Tatsuguchi M., Huang Z. P., Chen J. F., Deng Z., Gunn B., Shumate J., Willis M. S., Selzman C. H., Wang D. Z., MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice Journal of Clinical Investigation 2009 119 9 2772 2786
87. Van Rooij E., Sutherland L. B., Qi X., Richardson J. A., Hill J., Olson E. N., Control of stress-dependent cardiac growth and gene expression by a microRNA Science 2007 316 5824 575 579 (Pubitemid 46683138)
88. Condorelli G., Latronico M. V. G., Dorn G. W., MicroRNAs in heart disease: putative novel therapeutic targets? European Heart Journal 2010 31 6 649 658
89. Naraba H., Iwai N., Assessment of the MicroRNA system in salt-sensitive hypertension Hypertension Research 2005 28 10 819 826 (Pubitemid 47400252)
90. Wang G. K., Zhu J. Q., Zhang J. T., Li Q., Li Y., He J., Qin Y. W., Jing Q., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans European Heart Journal 2010 31 6 659 666
91. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N., Plasma miR-208 as a biomarker of myocardial injury Clinical Chemistry 2009 55 11 1944 1949
92. Tijsen A. J., Creemers E. E., Moerland P. D., De Windt L. J., Van Der Wal A. C., Kok W. E., Pinto Y. M., MiR423-5p as a circulating biomarker for heart failure Circulation Research 2010 106 6 1035 1039
93. Jordan S. D., Krger M., Willmes D. M., Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism Nature Cell Biology 2011 13 434 446
94. Um S. H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P. R., Kozma S. C., Auwerx J., Thomas G., Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity Nature 2004 431 7005 200 205 (Pubitemid 39243474)
95. Huang H. Y., Chien C. H., Jen K. H., Huang H. D., RegRNA: an integrated web server for identifying regulatory RNA motifs and elements Nucleic Acids Research 2006 34 W429 W434
96. Affymetrix Data sheet GeneChip miRNA Array
97. Schickel R., Park S. M., Murmann A. E., Peter M. E., miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1 Molecular cell 2010 38 6 908 915
98. Wellner U., Schubert J., Burk U. C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V. G., Morton J., Sansom O., Schler J., Stemmler M. P., Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T., The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature cell biology 2009 11 12 1487 1495
99. Spies C. D., Sander M., Stangl K., Fernandez-Sola J., Preedy V. R., Rubin E., Andreasson S., Hanna E. Z., Kox W. J., Effects of alcohol on the heart Current Opinion in Critical Care 2001 7 5 337 343 (Pubitemid 33064363)
100. Jones W. K., A murine model of alcoholic cardiomyopathy A role for zinc and metallotheienin in fibrosis American Journal of Pathology 2005 167 301 304 (Pubitemid 43026087)
101. Piano M. R., Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology Chest 2002 121 5 1638 1650 (Pubitemid 34499683)
102. Ren J., Wold L. E., Mechanisms of alcoholic heart disease Therapeutic Advances in Cardiovascular Disease 2008 2 6 497 506
103. Kloner R. A., Rezkalla S. H., To drink or not to drink? That is the question Circulation 2007 116 11 1306 1317 (Pubitemid 47517542)
104. WHO, 20082013 Action Plan for Global Strategy for the Prevention and Control of Noncommunicable Diseases 2008 Geneva, Switzerland World Health Organization
105. Ting J. W., Lautt W. W., The effects of acute, chronic and prenatal exposure on inulin sensitivity Pharmacology Therapeutics 2006 11 346 373 (Pubitemid 43832000)
106. Lucas D. L., Brown R. A., Wassef M., Giles T. D., Alcohol and the cardiovascular system: research challenges and opportunities Journal of the American College of Cardiology 2005 45 12 1916 1924 (Pubitemid 40814109)
107. Vernary M., Balkau B., Moreau J. G., Sigalas J., Chesnier M. C., Ducimeteriere P., Alcohol consumption and insulin resistance syndrome parameters.: associations and evolutions in a longitudinal analysis of the French DESIR cohort Annals of Epidemiology 2004 14 209 214 (Pubitemid 38249335)
108. Fan A. Z., Russell M., Naimi T., Patterns of alcohol consumption and the metabolic syndrome The Journal of Clinical Endocrinology Metabolism 2008 93 3833 3838
109. Limin T., Hou X., Liu J., Zhang X., Sun N., Gao L., Zhao J., Chronic ethanol consumption resulting in the downregulation of insulin receptor- subunit, insulin receptor substrate-1, and glucose transporter 4 expression in rat cardiac muscles Alcohol 2009 43 1 51 58
110. Li S. Y., Ren J., Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress Journal of Molecular and Cellular Cardiology 2008 44 6 992 1001
111. Li S. Y., Gilbert S. A. B., Li Q., Ren J., Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress Journal of Molecular and Cellular Cardiology 2009 47 2 247 255
112. Li Q., Ren J., Chronic alcohol consumption alters mammalian target of rapamycin (mTOR), reduces ribosomal p70s6 kinase and p4E-BP1 levels in mouse cerebral cortex Experimental Neurology 2007 204 2 840 844 (Pubitemid 46497062)
113. Elamin B. K., Callegari E., Gramantieri L., Sabbioni S., Negrini M., MicroRNA response to environmental mutagens in liver. Mutation Research. In press
114. Dolganiuc A., Petrasek J., Kodys K., Catalano D., Mandrekar P., Velayudham A., Szabo G., MicroRNA expression profile in lieber-decarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice Alcoholism: Clinical and Experimental Research 2009 33 10 1704 1710
115. Tang Y., Banan A., Forsyth C. B., Fields J. Z., Lau C. K., Zhang L. J., Keshavarzian A., Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease Alcoholism: Clinical and Experimental Research 2008 32 2 355 364
116. Wang N., Zhou Z., Liao X., Zhang T., Role of microRNAs in cardiac hypertrophy and heart failure IUBMB Life 2009 61 6 566 571
117. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., Van Laake L. W., Doevendans P. A., Mummery C. L., Borlak J., Haverich A., Gross C., Engelhardt S., Ertl G., Bauersachs J., MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure Circulation 2007 116 3 258 267 (Pubitemid 47196561)
118. Collins G. B., Brosnihan K. B., Zuti R. A., Messina M., Gupta M. K., Neuroendocrine, fluid balance, and thirst responses to alcohol in alcoholics Alcoholism: Clinical and Experimental Research 1992 16 2 228 233
119. Cheng C. P., Cheng H. J., Cunningham C., Shihabi Z. K., Sane D. C., Wannenburg T., Little W. C., Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy Circulation 2006 114 3 226 236 (Pubitemid 44313579)
120. Jing L., Li W. M., Zhou L. J., Li S., Kou J. J., Song J., Expression of renin-angiotensin system and peroxisome proliferator- activated receptors in alcoholic cardiomyopathy Alcoholism: Clinical and Experimental Research 2008 32 11 1999 2007
121. Fernndez-Sol J., Nicols J. M., Oriola J., Sacanella E., Estruch R., Rubin E., Urbano-Mrquez A., Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy Annals of Internal Medicine 2002 137 5 I 321 326 (Pubitemid 34977133)
122. Aroor A. R., Shukla S. D., MAP kinase signaling in diverse effects of ethanol Life Sciences 2004 74 19 2339 2364 (Pubitemid 38293254)
123. Izawa Y., Yoshizumi M., Fujita Y., Ali N., Kanematsu Y., Ishizawa K., Tsuchiya K., Obata T., Ebina Y., Tomita S., Tamaki T., ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells Experimental Cell Research 2005 308 2 291 299
124. Alfarano C., Sartiani L., Nidiani C., Functional coupling of angiotensin II type 1 receptor with insulin resistance of energy substrate uptakes in immortalized cardiomyocytes (HL-1 cells) British Journal of Pharmacology 2008 153 907 914 (Pubitemid 351328928)
125. Jeppesen P. L., Christensen G. L., Schneider M., Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts andmyocytes British Journal of Pharmacology 2011 164 2 394 404
126. Doser T. A., Turdi S., Thomas D. P., Epstein P. N., Li S. Y., Ren J., Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction Circulation 2009 119 14 1941 1949
127. Remenyi J., Hunter C. J., Cole C., Ando H., Impey S., Monk C. E., Martin K. J., Barton G. J., Hutvagner G., Arthur J. S. C., Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins Biochemical Journal 2010 428 2 281 291
128. Li S. Y., Li Q., Shen J. J., Dong F., Sigmon V. K., Liu Y., Ren J., Attenuation of acetaldehyde-induced cell injury by overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role of MAP kinase signaling Journal of Molecular and Cellular Cardiology 2006 40 2 283 294 (Pubitemid 43152384)
129. Paroo Z., Ye X., Chen S., Liu Q., Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling Cell 2009 139 1 112 122
130. Buss S. J., Riffel J. H., Katus H. A., Hardt S. E., Augmentation of autophagy by mTOR-inhibition in myocardial infarction: when size matters Autophagy 2010 6 2 304 306
131. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., Levine B., Sadoshima J., Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy Circulation Research 2007 100 6 914 922 (Pubitemid 46555697)
132. Buss S. J., Muenz S., Riffel J. H., Malekar P., Hagenmueller M., Weiss C. S., Bea F., Bekeredjian R., Schinke-Braun M., Izumo S., Katus H. A., Hardt S. E., Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction Journal of the American College of Cardiology 2009 54 25 2435 2446
133. Ge W., Ren J., mTOR-STAT3-notch signaling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism. Journal of Cellular and Molecular Medicine. In press
134. Zhang Y., Ren J., ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications Pharmacology Therapeutics 2011 132 1 86 95
135. Penumathsa S. V., Thirunavukkarasu M., Zhan L., Maulik G., Menon V. P., Bagchi D., Maulik N., Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium Journal of Cellular and Molecular Medicine 2008 12 6A 2350 2361
136. Penumathsa S. V., Thirunavukkarasu M., Samuel S. M., Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury Biochimica et Biophysica Acta 2009 1792 39 48
137. Russell R. R., Bergeron R., Shulman G. I., Young L. H., Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR American Journal of Physiology 1999 277 2 H643 H649 (Pubitemid 29415978)
138. Chen L. Y., Wang F. R., Sun X. L., Zhou J., Gao L., Jiao Y. L., Hou X. L., Qin C. Y., Zhao J. J., Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium Experimental and Molecular Medicine 2010 42 3 205 215
139. Brown B. D., Naldini L., Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications Nature Reviews Genetics 2009 10 8 578 585
140. Broderick J. A., Zamore P. D., MicroRNA therapeutics. Gene Therapy. In press
141. Sayed D., Abdellatif M., MicroRNAs in development and disease Physiological Reviews 2011 91 3 827 887
142. Esau C., Davis S., Murray S. F., Yu X. X., Pandey S. K., Pear M., Watts L., Booten S. L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B. A., Freier S., Bennett C. F., Bhanot S., Monia B. P., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metabolism 2006 3 2 87 98
143. Krtzfeldt J., Rajewsky N., Braich R., Rajeev K. G., Tuschl T., Manoharan M., Stoffel M., Silencing of microRNAs in vivo with 'antagomirs' Nature 2005 438 7068 685 689
144. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M. A., Licht J. D., Pena J. T. R., Rouhanifard S. H., Muckenthaler M. U., Tuschl T., Martin G. R., Bauersachs J., Engelhardt S., MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 2008 456 7224 980 984
145. Ebert M. S., Neilson J. R., Sharp P. A., MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nature Methods 2007 4 9 721 726 (Pubitemid 47338166)
146. Sayed D., Rane S., Lypowy J., He M., Chen I. Y., Vashistha H., Yan L., Malhotra A., Vatner D., Abdellatif M., MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Molecular Biology of the Cell 2008 19 8 3272 3282
147. Oba S., Kumano S., Suzuki E., Nishimatsu H., Takahashi M., Takamori H., Kasuya M., Ogawa Y., Sato K., Kimura K., Homma Y., Hirata Y., Fujita T., miR-200b precursor can ameliorate renal tubulointerstitial fibrosis PLoS ONE 2010 5 10